Therapeutic leukapheresis in patients with leukostasis secondary to acute myelogenous leukemia

Journal of Clinical Apheresis

Volumn 26, Issue 4, 2011, Pages 181-185

  De Santis, Gil Cunha ^a   De Oliveira, Luciana Correa Oliveira ^a   Romano, Lucas Gabriel Maltoni ^a   Almeida Prado Jr , Benedito De Pina ^a   Simoes, Belinda Pinto ^a   Rego, Eduardo Magalhaes ^a   Covas, Dimas Tadeu ^a   Falcao, Roberto Passetto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

acute myeloid leukemia; hyperleukocytosis; leukapheresis; leukostasis

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; LEUKAPHERESIS; LEUKOCYTE COUNT; LEUKOSTASIS; MALE; MORTALITY; OVERALL SURVIVAL; SURVIVAL RATE; TREATMENT RESPONSE;

ADULT; AGED; FEMALE; HUMANS; LEUKAPHERESIS; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTE COUNT; LEUKOSTASIS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT FAILURE; YOUNG ADULT;

EID: 80051546625     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20290     Document Type: Article

References (20)

1. Dutcher JP, Schiffer CA, Wiernik PH,. Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival. J Clin Oncol 1987; 5: 1364-1372.
2. Greenwood MJ, Seftel MD, Richardson C, Barbaric D, Barnett MJ, Bruyere H, Forrest DL, Horsman DE, Smith C, Song K, Sutherland HJ, Toze CL, Nevill TJ, Nantel SH, Hogge DE,. Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia. Leuk Lymphoma 2006; 47: 1245-1252. (Pubitemid 44269630)
3. Oliveira LC, Romano LG, Prado-Junior BP, Covas DT, Rego EM, De Santis GC,. Outcome of acute myeloid leukemia patients with hyperleukocytosis in Brazil. Med Oncol 2010; 27: 1254-1259.
4. Porcu P, Cripe LD, Ng EW, Bhatia S, Danielson CM, Orazi A, Mccarthy LJ,. Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management. Leuk Lymphoma 2000; 39: 1-18. (Pubitemid 30662024)
5. Zhang W, Zhang X, Fan X, Li D, Qiao Z,. Effect of ICAM-1 and LFA-1 in hyperleukocytic acute myeloid leukaemia. Clin Lab Haematol 2006; 28: 177-182.
6. Stucki A, Rivier AS, Gikic M, Monai N, Schapira M, Spertini O,. Endothelial cell activation by myeloblasts: molecular mechanisms of leukostasis and leukemic cell dissemination. Blood 2001; 97: 2121-2129. (Pubitemid 32239095)
7. Cavenagh JD, Gordon-Smith EC, Gordon MY,. The binding of acute myeloid leukemia blast cells to human endothelium. Leuklymphoma 1994; 16: 19-29.
8. Creutzig U, Zimmermann M, Reinhardt D, Dworzak M, Stary J, Lehrnbecher T,. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol 2004; 22: 4384-4393. (Pubitemid 41185159)
9. Lester TJ, Johnson JW, Cuttner J,. Pulmonary leukostasis as the single worst prognostic factor in patients with acute myelocytic leukemia and hyperleukocytosis. Am J Med 1985; 79: 43-48. (Pubitemid 15072945)
10. Lichtman MA, Rowe JM,. Hyperleukocytic leukemias: rheological, clinical, and therapeutic considerations. Blood 1982; 60: 279-283. (Pubitemid 12048667)
11. Porcu P, Danielson CF, Orazi A, Heerema NA, Gabig TG, Mccarthy LJ,. Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate. Br J Haematol 1997; 98: 433-436. (Pubitemid 27345121)
12. Giles FJ, Shen Y, Kantarjian HM, Korbling MJ, O'Brien S, Anderlini P, Donato M, Pierce S, Keating MJ, Freireich EJ, Estey E,. Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long-term survival. Leuk Lymphoma 2001; 42: 67-73. (Pubitemid 32700923)
13. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C,. Proposed revised criteria for the classification of acute myeloid leukemia. a report of the French-American-British cooperative group. Ann Intern Med 1985; 103: 620-625.
14. Marbello L, Ricci F, Nosari AM, Turrini M, Nador G, Nichelatti M, Tedeschi A, Vismara E, Morra E,. Outcome of hyperleukocytic adult acute myeloid leukaemia: a single-center retrospective study and review of literature. Leuk Res 2008; 32: 1221-1227.
15. Bug G, Anargyrou K, Tonn T, Bialleck H, Seifried E, Hoelzer D, Ottmann OG,. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis. Transfusion 2007; 47: 1843-1850. (Pubitemid 47438551)
16. Blum W, Porcu P,. Therapeutic apheresis in hyperleukocytosis and hyperviscosity syndrome. Semin Thromb Hemost 2007; 33: 350-354. (Pubitemid 46878107)
17. Azoulay E, Fieux F, Moreau D, Thiery G, Rousselot P, Parrot A, Le Gall JR, Dombret H, Schlemmer B,. Acute monocytic leukemia presenting as acute respiratory failure. Am J Respir Crit Care Med 2003; 167: 1329-1333. (Pubitemid 36609715)
18. Kasner MT, Laury A, Kasner SE, Carroll M, Luger SM,. Increased cerebral blood flow after leukapheresis for acute myelogenous leukemia. Am J Hematol 2007; 82: 1110-1112. (Pubitemid 350209857)
19. Thiebaut A, Thomas X, Belhabri A, Anglaret B, Archimbaud E,. Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis. Ann Hematol 2000; 79: 501-506.
20. Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz BH,. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the apheresis applications Committee of the American Society for Apheresis. J Clin Apher 2010; 25: 83-177.